Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Nirsevimab
This webpage features the drug dictionary entry for nirsevimab, providing the National Cancer Institute's definition. It describes nirsevimab as a special type of medicine called …
Ask aRCie
ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season
This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of …
The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access
2024
· University Medical Center Utrecht,
· Yenepoya University,
· University of Edinburgh,
· National Institutes of Health (NIH),
· London School of Hygiene and Tropical Medicine,
· London School of Hygiene & Tropical Medicine
This article is about the fight against respiratory syncytial virus (RSV), a major cause of illness in infants and older adults. It describes new vaccines …
Beyfortus-nirsevimab injection (Drug Label Information)
2024
· National Library of Medicine
This webpage provides drug label information for the Beyfortus- nirsevimab injection. It describes the drug's dosage, forms, and strengths. Beyfortus is given as an injection …
Nirsevimab (Beyfortus) Product & Ordering Information
This webpage provides information about nirsevimab (Beyfortus), describing the different doses available, how to order and store it, and its cost. Practices need to forecast …
Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024
This article is about a study on RSV vaccination for pregnant women and their babies in the U.S. It describes how RSV is a common …
Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024
This report looks at a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) illness and hospitalization among Alaska Native children in …
Nirsevimab Frequently Asked Questions
This webpage provides answers to frequently asked questions (FAQs) about nirsevimab, a monoclonal antibody used to prevent RSV in infants and young children. Topics include …
What Is the New RSV Immunization for Infants?
This short video discusses a new FDA-approved product that prevents serious RSV disease in children. It's not a typical vaccine but a monoclonal antibody given …
Nirsevimab: Alleviating the Burden Of RSV Morbidity in Young Children
2024
· Duke-NUS Medical School,
· KK Women's & Children's Hospital,
· University of New South Wales,
· Macquarie University,
· National Centre for Immunisation Research and Surveillance (NCIRS)
This article reviews the real-world data that supports the effectiveness of nirsevimab, a monoclonal antibody that helps protect young children from RSV. Studies have demonstrated …